DK1237904T3 - 14,15-beta-methylensubstituerede androgener - Google Patents

14,15-beta-methylensubstituerede androgener

Info

Publication number
DK1237904T3
DK1237904T3 DK00993259T DK00993259T DK1237904T3 DK 1237904 T3 DK1237904 T3 DK 1237904T3 DK 00993259 T DK00993259 T DK 00993259T DK 00993259 T DK00993259 T DK 00993259T DK 1237904 T3 DK1237904 T3 DK 1237904T3
Authority
DK
Denmark
Prior art keywords
methylene
beta
androgens
substituted androgens
substituted
Prior art date
Application number
DK00993259T
Other languages
Danish (da)
English (en)
Inventor
Der Louw Jaap Van
Bursi Roberta Buma
Gooyer Marcel Evert De
Dirk Leysen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1237904T3 publication Critical patent/DK1237904T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00993259T 1999-12-02 2000-11-29 14,15-beta-methylensubstituerede androgener DK1237904T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204080 1999-12-02

Publications (1)

Publication Number Publication Date
DK1237904T3 true DK1237904T3 (da) 2006-06-06

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00993259T DK1237904T3 (da) 1999-12-02 2000-11-29 14,15-beta-methylensubstituerede androgener

Country Status (27)

Country Link
US (1) US6706700B2 (cg-RX-API-DMAC10.html)
EP (1) EP1237904B1 (cg-RX-API-DMAC10.html)
JP (1) JP2003515543A (cg-RX-API-DMAC10.html)
CN (1) CN1166680C (cg-RX-API-DMAC10.html)
AR (1) AR026655A1 (cg-RX-API-DMAC10.html)
AT (1) ATE317396T1 (cg-RX-API-DMAC10.html)
AU (1) AU778017B2 (cg-RX-API-DMAC10.html)
CA (1) CA2390226A1 (cg-RX-API-DMAC10.html)
CO (1) CO5251441A1 (cg-RX-API-DMAC10.html)
CY (1) CY1106086T1 (cg-RX-API-DMAC10.html)
CZ (1) CZ301376B6 (cg-RX-API-DMAC10.html)
DE (1) DE60025958T2 (cg-RX-API-DMAC10.html)
DK (1) DK1237904T3 (cg-RX-API-DMAC10.html)
ES (1) ES2258037T3 (cg-RX-API-DMAC10.html)
HK (1) HK1047596B (cg-RX-API-DMAC10.html)
HU (1) HUP0203611A3 (cg-RX-API-DMAC10.html)
IL (1) IL149424A (cg-RX-API-DMAC10.html)
MX (1) MXPA02004939A (cg-RX-API-DMAC10.html)
NO (1) NO322422B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ518753A (cg-RX-API-DMAC10.html)
PE (1) PE20011033A1 (cg-RX-API-DMAC10.html)
PL (1) PL202999B1 (cg-RX-API-DMAC10.html)
RU (1) RU2242479C2 (cg-RX-API-DMAC10.html)
SK (1) SK287095B6 (cg-RX-API-DMAC10.html)
TW (1) TWI275593B (cg-RX-API-DMAC10.html)
WO (1) WO2001040255A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200203536B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
EP1470151B1 (en) * 2002-01-21 2009-12-30 N.V. Organon Process for the preparation of 7-alpha-methylsteroids
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
AU2012320423C1 (en) * 2011-10-07 2018-01-25 Estetra Srl Process for the production of estetrol
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN111621141B (zh) * 2020-06-12 2022-04-08 广西大学 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (de) 1995-10-10 1997-04-17 Jenapharm Gmbh Steroide mit einer 14, 15-Methylengruppe
DE19827522A1 (de) * 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
ATE228143T1 (de) 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene

Also Published As

Publication number Publication date
NO20022564D0 (no) 2002-05-30
NO322422B1 (no) 2006-10-02
IL149424A (en) 2007-05-15
ZA200203536B (en) 2003-08-04
CN1402735A (zh) 2003-03-12
US6706700B2 (en) 2004-03-16
PL355689A1 (en) 2004-05-17
CZ20021894A3 (cs) 2002-08-14
AR026655A1 (es) 2003-02-19
CA2390226A1 (en) 2001-06-07
DE60025958D1 (de) 2006-04-20
HK1047596B (en) 2006-04-21
AU2838301A (en) 2001-06-12
CZ301376B6 (cs) 2010-02-03
PL202999B1 (pl) 2009-08-31
SK287095B6 (sk) 2009-12-07
NZ518753A (en) 2004-05-28
HK1047596A1 (en) 2003-02-28
SK7582002A3 (en) 2002-09-10
DE60025958T2 (de) 2006-07-27
RU2242479C2 (ru) 2004-12-20
HUP0203611A2 (hu) 2003-03-28
US20030100543A1 (en) 2003-05-29
WO2001040255A2 (en) 2001-06-07
WO2001040255A3 (en) 2001-11-15
JP2003515543A (ja) 2003-05-07
NO20022564L (no) 2002-05-30
MXPA02004939A (es) 2003-05-23
ATE317396T1 (de) 2006-02-15
CY1106086T1 (el) 2011-06-08
CN1166680C (zh) 2004-09-15
EP1237904B1 (en) 2006-02-08
PE20011033A1 (es) 2001-10-11
CO5251441A1 (es) 2003-02-28
HUP0203611A3 (en) 2004-07-28
TWI275593B (en) 2007-03-11
AU778017B2 (en) 2004-11-11
ES2258037T3 (es) 2006-08-16
IL149424A0 (en) 2002-11-10
EP1237904A2 (en) 2002-09-11

Similar Documents

Publication Publication Date Title
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
MA25499A1 (fr) Contacteur-disjoncteur.
MA26849A1 (fr) 4-pyridinyle-n-acyl-l-phenylalanines.
ATE317396T1 (de) 14,15-beta-methylen substituierte androgene
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
ITBO990359A0 (it) Elettromandrino .
DE60029755D1 (de) Congawandschutz.
DK1149106T3 (da) 4,5-azolo-oxindoler
EP1192168A4 (en) galectin
ITBO990358A0 (it) Elettromandrino .
DE60020998D1 (de) Seilklemme
ES1042496Y (es) "pilona sumible".
ES1044367Y (es) Piñata mejorada.
ES1044838Y (es) Friegasuelos.
ITSS990004V0 (it) Piramide - ricordo.
ES1044013Y (es) Nueva cantonera mejorada.
SE9900910D0 (sv) FreezeBox 2000
SE9901602D0 (sv) Jet-tröska 2000
DE60017150D1 (de) 1,4,5,6 -tetrahydropyrimidine-derivative als vitronectin-hemmer
ES1042809Y (es) Esponja-estropajo mejorado.
IT1313922B1 (it) Elettromandrino perfezionato.
ITPS990017V0 (it) Leeran 1 (lorean)
ES1042445Y (es) Guardabolsas.
IT247637Y1 (it) Tritapepe.